
Loading, please wait...

Loading, please wait...

Managing pediatric speech disorders requires a nuanced approach, especially when dealing with co-occurring stuttering and speech sound challenges. A recent scoping review published in the American Journal of Speech-Language Pathology highlights a significant gap in empirical research for children facing these complex communication issues. While many clinicians encounter this dual diagnosis, high-level evidence to guide specific intervention remains scarce. Consequently, practitioners often navigate treatment using a mix of expert opinions and established frameworks to support their patients.
The study analyzed thirty-four primary items, including intervention studies, surveys, and qualitative data. Notably, researchers found only six intervention studies specifically targeting this population. Most current guidance stems from expert opinions found in textbooks and professional websites rather than large-scale randomized controlled trials. For instance, in India, the All India Institute of Speech and Hearing notes that nearly 10% of communication disorder cases involve stuttering. Because of this high prevalence, the lack of standardized protocols creates significant hurdles for both pediatricians and speech-language pathologists (SLPs).
Moreover, clinical observations suggest that treating both disorders concurrently may be more effective than a sequential approach. Recent case series indicate that direct intervention, such as the Lidcombe Program paired with individualized phonology therapy, can yield positive results. However, children with co-occurring conditions may face a higher risk of relapse compared to those with a single diagnosis. Therefore, clinicians should consider longer maintenance periods and frequent follow-up assessments to ensure lasting fluency and speech clarity.
Early identification remains vital because speech development peaks between ages two and five. If a child presents with both dysfluency and sound errors, a multi-faceted assessment is absolutely necessary. Pediatricians should refer these children to specialized clinics as soon as symptoms appear. Since empirical data is limited, clinicians must weigh available clinical frameworks against the specific needs of each child. Additionally, actively involving parents in the therapeutic process enhances the long-term stability of treatment gains for children with speech disorders.
Research indicates that approximately 30% to 44% of children who stutter also exhibit a speech sound disorder. This high rate of concomitance suggests that clinicians should routinely screen for both during initial pediatric evaluations.
Yes, contemporary expert opinion favors concurrent intervention. Addressing both issues simultaneously can be safe and efficient, provided the clinician carefully monitors the child's frustration levels and adapts the therapy intensity accordingly.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider for any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Collins J et al. Evidence for the Treatment of Co-Occurring Stuttering and Speech Sound Disorders in Children: A Scoping Review. Am J Speech Lang Pathol. 2026 Jun 03. doi: 10.1044/2026_AJSLP-25-00312. PMID: 42234467.
Unicomb R, et al. Evidence for the treatment of co-occurring stuttering and speech sound disorder: A clinical case series. Int J Speech Lang Pathol. 2017 Jun;19(3):251-264.
Konadath S, et al. Prevalence of communication disorders in a rural population of India. J Hear Sci. 2013;3(2):41-49.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A scoping review reveals limited evidence for treating co-occurring stuttering and speech sound disorders, emphasizing the need for more clinical research....
4 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today